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The incorporation of proteins into calcium phosphate (Ca–P) coatings is expected to alter their properties.
The aim of this work is, therefore, to study the effect of protein concentration on the formation of Ca–P ﬁlm. A
biodegradable blend of corn starch/ethylene vinyl alcohol (SEVA-C) was used as substrate and bioactive glass
(45S5 Bioglass®) was used as a nucleating agent. Bovine serum albumin (BSA) and α-amylase were added,
separately, at a concentration of 0.5, 1, and 5 mg/mLto simulated body ﬂuid (SBF) solutions, at the nucleation
stage.
The incorporation of protein molecules was shown to affect the properties of Ca–P coatings in terms of
morphology, composition and crystallinity. Both proteins seem to inhibit in some extent and/or retard the
growth of Ca–P nuclei at 0.5 and 5 mg/mL concentrations. FTIR analyses revealed the presence of phosphate
and carbonate groups, conﬁrming the formation of a Ca–P layer. The characteristic groups of proteinmolecules
were also detected on the IR spectra,which indicate the efﬁcient incorporation of the proteins into the coatings.
When α-amylase was added to the SBF solution the production of reducing sugars was detected, proving the
retention of enzyme activity. These results suggest the carrier potential of Ca–P coatings for the sustained
delivery of other biologically active proteins and consequently with a strong potential for inducing bone tissue
regeneration.
© 2008 Elsevier B.V. All rights reserved.
1. Introduction
Design strategies for creating biomimetic materials, that direct the
interaction with biological systems, such as the formation of tissue
surrounding implants or regeneration within artiﬁcial matrices, leads
to a new interdisciplinary ﬁeld which could be called molecular
engineering [1,2].
It is well known that the ideal implant for bone should demand
good biocompatibility, without the possibility of inﬂammation or
foreign body reactions, and present a surface conductive that will
induce osseointegration, regardless of the implantation site [3,4]. For
bone replacement, a strong bonding with host bone and a osteocon-
ductive surface are also required. Hydroxyapatite (HA), one of the
major constituent of bone [5–7], has been often designated as
osseointegrating and/or osteoconductive material [8]. Due to its
good biocompatibility [5–7] and efﬁcacy in promoting biointegration
for implants in hard [9], this bioactive ceramic has been used in
various forms during the last decades.
Calcium phosphate (Ca–P) coatings, produced by biomimetic
routes, have shown excellent osteoconductive ability and simulta-
neously offering an opportunity to incorporate protein molecules
without compromising their activity, as they are generated under
physiological conditions. Therefore, these Ca–P coatings can be used
as a vehicle for the controlled release of biologically active molecules,
such as bone growth factors (bone morphogenetic proteins – BMPs
and other osteoinductive proteins). With this methodology, bioactive
proteins can be directly integrated in the structure of Ca–P coatings,
maintaining their conformation close to their native form, and thus
improve the functionality of the inorganic layer at the implant
interface. For instance, with the plasma-spraying technique for
producing Ca–P coatings, no active biomolecules can be added during
the processing, due to the extremely high temperatures generated by
this coating technique.
Moreover, if this coating is applied on a biodegradable polymer,
such combination should also integrate within tissues, and progres-
sively be degraded and fully replaced by bone material.
Several works have been reported [10–23] in the literature
investigating the inﬂuence of protein incorporation on the formation
of Ca–P coatings produced bymeans of using biomimetic routes. It has
been demonstrated that using these methologies [12,16,20–24]
different proteins can be directly integrated into the structure of Ca–
P coatings and also their activity is retained [21–25], being their
release mainly controlled by the dissolution behaviour of the coating
Materials Science and Engineering C 29 (2009) 913–918
⁎ Corresponding author. 3B's Research Group – Biomaterials, Biodegradables and
Biomimetics, Department of Polymer Engineering, University of Minho, Headquarters of
the European Institute of Excellence on Tissue Engineering and Regenerative Medicine,
AvePark, Zona Industrial da Gandra, 4806-909 Caldas das Taipas, Guimarães, Portugal.
E-mail address: belinha@dep.uminho.pt (I.B. Leonor).
0928-4931/$ – see front matter © 2008 Elsevier B.V. All rights reserved.
doi:10.1016/j.msec.2008.08.003
Contents lists available at ScienceDirect
Materials Science and Engineering C
j ourna l homepage: www.e lsev ie r.com/ locate /msec
[16,17,23,26]. Speciﬁc hydrolytic enzymes could be also incorporated
to tailor the degradation kinetics of the substrate, which presents an
alternative strategy to control the degradation rate of polymeric
biomaterials. Such system would be particularly useful in tissue
engineering scaffolding by allowing the growth of new tissue into the
degrading construct. This is a completely novel approach to tailor the
degradation kinetics of biodegradable biomaterials. On the other
hand, the incorporation of protein molecules may alter the properties
of the coatings and thus these effects need to be evaluated. Therefore,
the main goal in this research work is to study the effect of protein
concentration on the formation of a Ca–P ﬁlm at physiological condi-
tions, aiming to establish optimal protein concentration for their
efﬁcient incorporation. These coatings may constitute an effectiveway
to provide osteoconductive as well as osteoinductive properties in a
single material. As the Ca–P layer undergoes degradation in vivo,
the proteins will be gradually released, which enhances the potential
of these coatings to serve as a slow-release carrier system for the
delivery of growth factors to the implantation site.
2. Materials and methods
2.1. Materials
The material used in this study was a biodegradable polymeric
blend of corn starch with poly (ethylene-vinyl alcohol) copolymer
(50/50 wt.%), designated as SEVA-C. Conventional injection moulding
technology (Klockner-Ferromatik Desma FM20, USA) was used to
produce 2×4 mm2 cross-section dumb-bell ASTM tensile samples.
Further details on the material processing and respective mechanical
properties can be found elsewhere [27–29].
A bioactive glass (45S5 Bioglass®) with the following composition:
45 SiO2, 24.5 CaO, 24.5 Na2O and 6.0 P2O5 in wt.%, was supplied by
NovaMin Technology (Alachua, Florida, USA). This glass powder was
used as precursor for calcium–phosphate ﬁlm deposition and, by laser
scattering analysis (Coulter LS 100 particle size analyser) it was
measured the particle size that was lower than 20 µm.
Bovine serum albumin (BSA, Fraction V) was obtained from Sigma
(USA) and α-amylase, from Bacillus amyloliquefaciens, was kindly
supplied by Genencor International, Inc. (USA).
2.2. Preparation of Ca–P coatings — adapted biomimetic route
The procedure used to produce Ca–P coating was based on the
methodology previously developed by Kokubo et al. [30] and further
adapted by Reis et al. [31,32]. Prior to the coating process, SEVA-C
samples were sterilized by ethylene oxide. Bioglass® (45S5) was
sterilised by immersion in ethanol solution (70%, v/v) and then dried
inside the laminar ﬂow cabinet. Protein and enzyme solutions were
reconstituted to a ﬁnal concentration of 0.5, 1 and 5 mg/mLin
simulated body ﬂuid (SBF) solution (pH 7.4) similar to human plasma
regarding ions concentration. SBF and protein solutions were
sterilized by ﬁltration (0.2 µm pore). All the subsequent procedures
Fig. 1. SEM micrographs of the Ca–P coatings on the surfaces of SEVA-C before coating and after 14 days in SBF (growth stage): (a) Control, (b, e) 0.5 mg/mL of BSA and α-amylase,
(c, f) 1.0 mg/mL of BSA and α-amylase, and (d, g) 5.0 mg/mL of BSA and α-amylase, added in the nucleation stage.
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were performed under sterile conditions in a vertical ﬂow laminar
cabinet to avoid samples and solutions contamination. The SEVA-C
samples were rolled on a bed of wet Bioglass® (45S5) particles and
immediately immersed in 15mL of 1.0 SBF solution, as control, and in
SBF solution containing different concentrations of BSA or α-amylase.
Incubation time was 7 days at 37 °C for the Ca–P nuclei formation
(nucleation stage). Following this period, samples were removed from
the incubation solution, immersed in a 1.5 SBF solution for 7 and
14 days in order to allow the growth the Ca–P nuclei (growth stage).
After each immersion period, samples were taken from the incubation
solution, rinsed with distilled water, dried at room temperature and
stored before the surface analysis. Incubation solutions were stored at
4 °C for ion concentration and enzyme activity determinations.
2.3. Ca–P coating analysis
2.3.1. SEM and EDS
Ca–P coatings morphology and presence of calcium, phosphorous
and silicon elements on the coating surface were analysed, before and
after soaking in SBF, by means of scanning electron microscopy (SEM)
coupled to energy dispersive spectroscopy (EDS) equipment (Leica
Cambridge S360, UK). Previously to EDS and SEM analysis, sample
surfaces were carbon coated (Fisons Instruments, Evaporation PSU
CA508, UK) and gold sputtered (Fisons Instruments, Sputter Coater
SC502, UK), respectively.
2.3.2. FTIR-ATR
The chemical structure of the coatings formed on the surface of
SEVA-C under the different studied conditions was analysed by Fourier
transform infrared spectroscopy with attenuated reﬂectance (FTIR-
ATR). All spectra were recorded using at least 64 scans and 2cm− 1
resolution in a FTIR spectrophotometer (Perkin-Elmer 1600 Series, USA)
with a single reﬂection ATR system (MKII Golden Gate™, Specac, UK).
2.3.3. TF-XRD
Thin-ﬁlm X-ray diffraction (TF-XRD, Philips X'Pert MPD, The
Netherlands) was used to characterise the crystalline/amorphous
nature of the ﬁlms and to identify any crystalline phases present after
the immersion in SBF (results were compared to non immersed
controls). The data collection was performed by 2θ scan method with
1° as incident beam angle using CuKα X-ray line and a scan speed of
0.05°/min in 2θ.
2.4. Solution analysis
Immersion solutions were analysed in order to determine the
concentrations of calcium, phosphorus, silicon and sodium elements
as a function of the immersion time. The elemental concentrations
were measured by inductively coupled plasma optical emission
spectroscopy (ICP-OES, JY 70 plus, Jobin Yvon, France). Duplicate
samples were analysed for each condition and immersion time.
In order to assess the presence, or not, of enzyme activity during
the coating preparation, the solutions were also analysed. α-Amylase
is an endo-speciﬁc enzyme which catalyses the hydrolysis of α-1,4-
glycosidic linkages of starch. The activity of α-amylase was monitored
by measuring the concentration of reducing sugars liberated into the
solution using the dinitrosalicylic acid (DNS) method [33].
3. Results and discussion
The effect of proteins on the formation of Ca–P coatings has been
subjected to an extensive research [10–23]. Most of these studies
aimed to investigate the possible role of plasma proteins on the
formation of an apatite layer in vivo, but few had exploited the
possibility of incorporating therapeutic agents into Ca–P ﬁlms to
develop a delivery system for their sustained release.
Proteins are highly surface-active molecules due to their amphi-
philic properties [34]. Hence, they can interact with any encountered
interface, generally leading to adsorption of the proteins [35,36],
responsible for a range of initial and fate-determining interactions
[37]. Albumin, speciﬁcally, was the protein selected for this study due
to its high concentration in the blood serum, favourable diffusion
coefﬁcient and ability to bind other molecules [38,39]. On the other
hand, α-amylase was also used, being considered as appropriate
to study enzymatic properties and due to its ability to interact with
starch-based materials [40].
Using a biomimetic coating methodology, it was possible to
incorporate biomolecules, such as BSA and α-amylase, but considerable
Fig. 2. EDS spectra of the Ca–P coatings on SEVA-C surface after the (a) nucleation stage
(7 days), and (b) growth stage (14 days) for 0.5 mg/mL of BSA.
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differences were observed. At high concentration (5mg/mL), α-amylase
presented an inhibitor effect, while BSA had the opposite effect.
Fig.1 shows the SEMmicrographs of the calciumphosphate coatings
onto SEVA-Csurfacebefore andafter soaking in SBF solution fordifferent
conditions after 14 days in the growth stage. In the control, it can be
observed a uniform Ca–P coating covering all of the SEVA-C substrate.
However, some signiﬁcant differences were found between the
distinct concentrations. At a concentration of 0.5 mg/mL of BSA, it can
be seen the formation of a uniform Ca–P ﬁlm, but not as dense as the
one obtained in the control (see Fig. 1b). Moreover, the Ca–P nuclei
growth was delayed and consequently, the ﬁlm did not grow as
function of immersion time.
For α-amylase, only the formation of Ca–P nuclei was observed.
The additional soaking in SBF did not promote the growth of the Ca–P
layer (see Fig. 1e). Quite the opposite was observed when the
concentration of the biomolecules was 1 mg/mL (Fig. 1c and f).
For both proteins, in the ﬁrst 7 days in the growth stage, the
formation of Ca–P ﬁlm was observed on the SEVA-C surface (data not
shown). Furthermore, as the soaking time increased, the Ca–P ﬁlm
becomes denser and compact. For higher concentrations, 5 mg/mL,
BSA and α-amylase induced different effects, as it is shown in Fig. 1d
and g. In the case of BSA, the ﬁlmwas extremely compact evidencing a
ﬁner microstructure at higher magniﬁcation: needle-like crystals
agglomerated to produce the so-called cauliﬂower morphology. At
higher concentration of α-amylase, the growth of Ca–P ﬁlm was
delayed as it can be seen in the Fig. 1g.
EDS analysis (Fig. 2) conﬁrmed the presence of silicon (Si) element
as well as the calcium (Ca) and phosphorus (P) elements in the
nucleation stage. In the growth stage, the P and Ca signals were
detected, where their signal intensity signiﬁcantly increased, indicat-
ing in turn density increase of the Ca–P coating. It was also detected
the decrease of silicon and the presence of chlorine being the later
derived from the SBF solution (Fig. 2b).
The TF-XRD patterns did not display the main characteristic peaks
of hydroxyapatite. In fact, it seems that the formed Ca–P layer is
mainly amorphous (data not shown).
The lower intensity of the apatite diffraction peaks indicates that in
the nucleation stage a much thinner apatite layer was formed on the
specimen surface. This fact was also observed for the other conditions.
Studies have been relating the presence of proteins with a lower
crystallinity of minerals, such as apatite in the bone [19,41,42].
In Fig. 3, the FTIR-ATR spectrum displays reﬂectance peaks of
phosphate group (PO43−) (around 1018cm− 1) for the control after
14 days in SBF during the growth stage (please see Fig. 3a).
When α-amylase and BSA were added to the SBF solution in the
nucleation stage, chemical changes were observed in the IR spectra at
1650cm− 1. This can be ascribed to the amide I band that represents
the stretching vibrations of C=O bonds in the backbone of the protein
(Fig. 3b and c) [43]. In turn, the obtained results could indicate the
adsorption of proteins on the surface of the substrate. In the growth
stage, the FT-IR spectra show bands centred at 1650cm− 1 that can be
also attributed to Amide I (Fig. 3b and c) [43]. For α-amylase, these
bands can only be observed for 1.0 mg/mL concentration (see Fig. 3c).
On the other hand, for 0.5 and 5mg/mL, the intensities of such bands
were not so intense. These results are correlated with the SEM
observation, since for 0.5 and 5 mg/mL of α-amylase, it was only
observed the formation of Ca–P nucleus and a delayed in the growth of
the Ca–P ﬁlm, as it is shown in Fig. 1e and g. Moreover, a small
shoulder associated with carbonate substitution at 1418cm− 1 and
phosphate band located at 1020cm− 1 respectively, were observed in
the collected spectra.
It was found that the adsorption of proteins on the mineral surface
can clearly alter the nucleation and growth process, acting as
promoters or inhibitors of biomineralisation, depending on the
concentration of adsorbed proteins [44]. Combes et al. [44] observed
that BSA had two opposite effects on the growth kinetics of
octacalcium phosphate (OCP) on type I collagen. At concentrations
lower than 10mg/mL, BSA favoured the growth of OCP, whereas at
higher concentrations (up to 60 mg/mL) BSA presented an inhibitory
effect. In the presence of about 1 mg/mL of BSA, the OCP growth rate
was twice higher than in the absence of BSA.
The variation of Ca and P concentrations as a function of immersion
time in SBF solution is shown in Fig. 4 for the different concentrations
of BSA and α-amylase for growth stage.
For the control, an increase in the amount of Si in the SBF can be
detected, which is attributed to the dissolution of the bioactive glass
Fig. 3. FTIR-ATR spectra of the SEVA-C surface before coating and after nucleation and growth stages, showing the more signiﬁcant bands detected on the coating in the various
conditions studied: control (a), BSA 1 mg/mL (b) and α-amylase 1 mg/mL (c).
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particles. This dissolution provides favourable sites for the formation
of Ca–P nuclei during the initial period of immersion. Then, as the
immersion time increases in the growth stage, Ca and P concentra-
tions decreased gradually probably due to the Ca–P formation by
consuming the calcium and phosphate ions in SBF.
In the presence of proteins, the amount of Si released to the
solution was higher for the concentration 5mg/mL, which means that
the dissolution of the bioactive glass particles was affected by the
presence of these proteins.
In the growth stage, there was a large number of Ca–P nuclei that
induced the spontaneous growth of Ca–P ﬁlm by consuming Ca and P
ions from 1.5 SBF solution.
For 1 mg/mL of BSA and α-amylase, it can be observed, as the
immersion time increases, a gradual decrease in the Ca and P
concentrations, probably due to the Ca–P formation by consuming
the calcium and phosphate ions in SBF. In the case of α-amylase, there
was a slight increase of the Ca concentration after 14 days in SBF. These
results might be related with the release of soluble reducing sugars to
the solution that may bring associated calcium ions (see Fig. 5).
On the other hand, for the 0.5 and 5 mg/mL concentrations in both
proteins, therewas a release of Ca to the solution aswell as an increase in
P concentration in the ﬁrst days of immersion in SBF during the growth
stage. As it was explained before, this can be due to the release of
reducing sugars into the solution, particularly for 5 mg/mL of α-
amylase.
The increase of Ca in the solution leads to the increase of the
supersaturation in the SBF solution and as result leads to the formation
of Ca–P layer with the subsequent decrease of Ca and P concentration in
SBF, conﬁrming the growth of Ca–P layer by consuming these ions.
Typical enzyme immobilisation methods require chemical mod-
iﬁcation of the solid matrix and the covalent attachment of the protein
to the matrix. This can result, in many cases, in loss of protein
bioactivity. Therefore, it is necessary to select adequate immobilisa-
tion techniques to preserve the structure and activity of the proteins.
The hydrolysis of starch is only possible by the pre-adsorption
of the enzyme onto the substrate. It is well known that the
adsorption of polysaccharide-degrading enzymes to insoluble sub-
strates is a pre-requisite step before catalysis and these enzymes
exhibit high afﬁnity and bind speciﬁcally to their substrates [45].
α-amylase is an endo-speciﬁc enzyme, which catalyses the hydro-
lysis of α-1,4-glycosidic linkages of starch to maltose and dextrins,
reducing the molecular size of starch. The activity of α-amylase can be
monitored by measuring the concentration of reducing sugars liberated
into the solution. In this particularwork, the incorporation ofα-amylase
wasused to investigate thepossibilityof controlling thedegradation rate
of starch-based polymers.
Fig. 5 shows the concentration of reducing sugars produced in the
various stages of the Ca–P formationwhen different concentrations of
α-amylase were incorporated at the nucleation stage. It can be seen
that after 7 days of incubation in the nucleation period, the production
of reducing sugars is enzyme-concentration dependent, which means
that for higher enzyme concentration, higher concentration of
reducing sugars was detected.
The enzymatic hydrolysis of solid substrates is normally char-
acterised by an enzyme saturation point, at which enzyme concentra-
tion, no further increase in the degradation rate is observed when
more enzyme is added [46]. This has been attributed to a decrease in
the exposed substrate surface as the enzyme molecules saturate the
surface and appears to be limiting the progress of catalysis.
In the growth stage, it is also observed the release of reducing
sugars, and their concentration increases with incubation time. These
ﬁndings reveal that α-amylase was efﬁciently incorporated into the
coating and remained active. A maximum of enzyme activity was
observed, however, when α-amylase was incorporated at
Fig. 4. Evolution of Ca and P concentrations in SBF as function of immersion time in the
growth stage for different concentrations of BSA (a) and α-amylase (b).
Fig. 5. Concentration of reducing sugars produced at the various stages of the Ca–P
formation when different concentrations of α-amylase were incorporated at the
nucleation period.
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concentration 1 mg/mL. This may indicate that for this concentration
higher percentages of enzyme were adsorbed on the polymer surface
during the nucleation stage. The efﬁcient incorporation of active α-
amylase into Ca–P coatings may be used as a method to control the
degradation rate of starch-based biomaterials.
The results found in this study are of importance, since they allow
the establishment of optimal protein concentrations to be incorpo-
rated in the coatings, in terms of incorporation efﬁciency and the
respective effects on the coating properties. In fact, we believe that
surfaces coated with biomimetic coatings, into which growth factors
or enzymes will be incorporated, hold great potential in bone tissue
engineering.
4. Conclusions
The supplementation of SBF with different concentration of
proteins with distinct properties at the nucleation stage, affected the
growth kinetics of a Ca–P layer. Better results were obtained for the
concentration of 1 mg/mL, in terms of coating growth and protein
incorporation. The incorporation of protein into Ca–P coatings enables
the possibility of tailoring their properties and this approach proved to
be useful in preserving the activities of enzymes. Herein, indicating
the carrier potential of calcium phosphate coatings for the sustained
delivery of other bioactive agents. These results enable deﬁnitively
for the new perspective of adding osteoinductive proteins or growth
factors into biomimetic coatings for inducing bone growth on the
implant surroundings.
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